Interferon‐α alone vs standard targeted therapiesQoL · previously untreated patients with mRCC1 finding from 1 reviewImmunotherapy for metastatic renal cell carcinoma 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 730 participantsLow